Navigation Links
Genzyme and Isis Begin Second Phase 3 Trial Of Mipomersen
Date:8/6/2008

us organisms. Isis is a joint owner of Regulus Therapeutics LLC, a joint venture focused on the discovery, development and commercialization of microRNA therapeutics. As an innovator in RNA-based drug discovery and development, Isis is the owner or exclusive licensee of over 1,500 issued patents worldwide. Additional information about Isis is available at http://www.isispharm.com.

Genzyme Safe Harbor Statement

This press release contains forward-looking statements, including without limitation, statements concerning mipomersen's safety and benefits for patients with high cholesterol, the development plan for mipomersen and FDA's requirements for its approval. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those forecasted. These risks and uncertainties include, among others: the timing of further discussions with FDA regarding the approval of mipomersen; the timing and content of submissions to and decisions made by the FDA relating to mipomersen; further analysis of clinical trial data; the results of other studies; the actual efficacy and safety of mipomersen; and the risks and uncertainties described in Genzyme's SEC reports filed under the Securities Exchange Act of 1934, including the factors discussed under the caption "Risk Factors" in Genzyme's Quarterly Report on Form 10-Q for the quarter ended March 31, 2008. Genzyme cautions investors not to place substantial reliance on the forward-looking statements contained in this press release. These statements speak only as of today's date and Genzyme undertakes no obligation to update or revise the statements.

Genzyme(R) is a registered trademark of Genzyme Corporation. All rights reserved.

Isis Safe Harbor Statement

This press release includes forward-looking statements regarding Isis' collaboration with Genzyme Corporation, its financial and business developme
'/>"/>

SOURCE Genzyme Corp.; Isis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Genzyme and Isis Complete Licensing of Mipomersen
2. Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients
3. Genzyme Genetics Announces Launch of Carrier Testing and Prenatal Diagnosis for Spinal Muscular Atrophy
4. Genzyme Announces Presentation of New Positive Data on Carticel(R)
5. Genzyme Corporation Selects Diplomat Specialty Pharmacy for 2008 Renagel Medicare Part D Assistance Program
6. Genzyme Completes Enrollment in Pivotal, Phase 2 Clinical Trial of Clofarabine in Adult AML
7. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
8. Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint
9. Light Sciences Oncology Begins Clinical Trials of Litx Therapy in Patients with Enlarged Prostate
10. Catalyst Pharmaceutical Partners, Inc. Begins Enrollment for U.S. Phase II Clinical Trial of CPP-109 in Patients with Methamphetamine Addiction
11. Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... , May 27, 2015  Maxim ... ) makes it easy to calibrate ... monitor or control unsanitary reuse of ... nonvolatile (NV) 1-Wire® memory. ... http://www.maximintegrated.com/en/products/digital/memory-products/DS28E80.html , Maxim,s gamma ...
(Date:5/27/2015)... , May 27, 2015  Foundation Health Care  (FDNH), ... related ancillary services, announced today it will present at ... 1-3, 2015 at Luxe Sunset Boulevard Hotel, ... on Tuesday, June 2 nd at 3:00pm and ... a one-on-one meeting please contact LD Micro. For more ...
(Date:5/27/2015)... UNION CITY, Calif. , May 27, 2015 /PRNewswire/ ... company manufacturing point-of-care blood analysis systems, announced today that ... and investor relations, transitioning into the role of chief ... the Jefferies 2015 Global Healthcare Conference on Thursday, June ... be held at the Grand Hyatt in ...
Breaking Medicine Technology:Gamma-Radiation-Resistant Memory Provides Calibration and Protects from Unsanitary Reuse in Medical Disposables 2Gamma-Radiation-Resistant Memory Provides Calibration and Protects from Unsanitary Reuse in Medical Disposables 3
... 19, 2011  The National Urban League (NUL) and the League ... Inc. (ESI) to resume negotiations and come to an agreement ... not reached, millions of Americans, especially in diverse and underserved ... 1, 2012. In an open letter to ...
... Dec. 19, 2011 /PRNewswire-iReach/ --  In an effort ... time and on schedule, Apothecary Shop Wholesale, Inc. ... is distributing a novel medication adherence aid called GlowCap®, ... that reminds patients to take their medication through sound ...
Cached Medicine Technology:The National Urban League and League of United Latin American Citizens Urge Express Scripts to Reach Agreement with Walgreens 2The National Urban League and League of United Latin American Citizens Urge Express Scripts to Reach Agreement with Walgreens 3The Apothecary Shops Incorporates Innovative Technology Into Patient Medication Reminders 2
(Date:5/27/2015)... “Heroin has never been more plentiful or cheaper, or ... says Harford County Sheriff Jeff Gahler, as quoted by the ... heroin related incidents in Baltimore, police resources are running thin. ... addiction and subsequent abuse before it turns into a fatal ... a drug and alcohol rehab facility specializing in heroin rehab. ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 For a limited ... Ghasri, is now offering discounts on facial fillers. Skin loses ... the age of 18. This lost collagen can lead to ... wrinkles and expression lines. Facial fillers are an excellent way ... turn to facial fillers to create a softer and more ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 A television ... MediaSource and Roswell Park Cancer Institute ... , The award-winning story, Cancer Can’t Win , ... Roswell Park Cancer Institute. The production team followed five ... several months as they received treatment from doctors and ...
(Date:5/27/2015)... founder of FACE, the award-winning beauty clinic, is detailing several ... the body’s largest organ and is exposed to many environmental ... skin cancer are diagnosed in the United States and over ... , There are several things people can do to ... the hours of 10 AM and 4 PM, when the ...
(Date:5/27/2015)... CT (PRWEB) May 27, 2015 CRN ... John Prinner as its new Chief Financial Officer. , ... Holdings, and prior to that held financial/operational executive positions ... Intensity, Vivaro Corp., Conversent Communications, Utilicom, and SNET. ... at PricewaterhouseCoopers. , At CRN, Prinner will be able ...
Breaking Medicine News(10 mins):Health News:The Price of Heroin in Baltimore Drops, Surging Use and Causing Rife Overdose Deaths 2Health News:The Price of Heroin in Baltimore Drops, Surging Use and Causing Rife Overdose Deaths 3Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Discounts on Facial Fillers 2Health News:MediaSource Wins New York Emmy® Award as Premier Health Care Storytellers 2Health News:MediaSource Wins New York Emmy® Award as Premier Health Care Storytellers 3Health News:In Recognition of National Melanoma Awareness Month, Beauty Guru Details Skin Tips to Prevent Cancer and Premature Aging 2Health News:CRN International Names New Chief Financial Officer 2
... counsel patients, it is key for clinicians of different ... syndrome, between two medical disorders - ALS and FTD ... new study, Catherine Lomen-Hoerth, from the University of California ... a research perspective, identifying the syndrome early is an ...
... lower quality of care because they typically have fewer staff ... the finding of a new UCSF-led analysis of quality of ... first-ever study focusing solely on staffing and quality at the ... in advance of print publication in Health Services ...
... more gray matter you have in the decision-making, thought-processing part ... and consequences. That may seem like an obvious conclusion, but ... Brookhaven National Laboratory is the first to show this link ... impairment of both structure and function in people addicted to ...
... HealthDay Reporter , TUESDAY, Nov. 29 (HealthDay News) -- Frequent ... brain damage leading to subtle but serious declines in thinking ... study, researchers used an advanced MRI technique to analyze changes ... who headed balls 436 times a year on average. Players ...
... , TUESDAY, Nov. 29 (HealthDay News) -- ,Creative ... are less creative, perhaps because being an original thinker ... to a new study. Harvard and Duke University ... would cheat in situations where they could justify their ...
... A groundbreaking new study shows that laws legalizing ... drop in traffic deaths and a five percent reduction ... legalization of medical marijuana reduces traffic fatalities through reducing ... of economics at the University of Colorado Denver who ...
Cached Medicine News:Health News:The implications of disease coexistence 2Health News:Low staffing and poor quality of care at nation's for-profit nursing homes 2Health News:Low staffing and poor quality of care at nation's for-profit nursing homes 3Health News:Gray matter in brain's control center linked to ability to process reward 2Health News:Gray matter in brain's control center linked to ability to process reward 3Health News:Could Soccer 'Headers' Cause Brain Injury? 2Health News:Could Soccer 'Headers' Cause Brain Injury? 3Health News:Creative Minds More Prone to Cheating 2Health News:Study shows medical marijuana laws reduce traffic deaths 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: